Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV

This study has been completed.
Information provided by (Responsible Party):
Bionor Immuno AS Identifier:
First received: April 14, 2008
Last updated: January 27, 2015
Last verified: August 2010